Synopsis of recent research by authors named "Rachid Baz"
- Rachid Baz's recent research focuses on advanced therapeutic strategies in multiple myeloma, including the integration of functional transcriptomic analysis and predictive biomarkers to optimize treatment outcomes for patients.
- His studies involve examining the safety and efficacy of innovative treatments like idecabtagene vicleucel and linvoseltamab, as well as assessing the incidence and management of treatment-related toxicities, including immune effector cell-associated enterocolitis and cardiotoxicity linked to carfilzomib.
- Additionally, Baz emphasizes the importance of individualized patient care by addressing treatment options that align with patient needs, preferences, and the latest clinical guidelines in managing relapsed and refractory multiple myeloma.
